Ninety One North America’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-36,520
| Closed | -$4.1M | – | 108 |
|
|
2020
Q2 | $4.1M | Sell |
36,520
-179,385
| -83% | -$20.1M | 0.43% | 50 |
|
|
2020
Q1 | $19.4M | Buy |
215,905
+4,153
| +2% | +$373K | 1.61% | 21 |
|
|
2019
Q4 | $22.9M | Sell |
211,752
-11,249
| -5% | -$1.22M | 1.87% | 23 |
|
|
2019
Q3 | $21.8M | Buy |
223,001
+53,717
| +32% | +$5.26M | 1.97% | 26 |
|
|
2019
Q2 | $22.2M | Buy |
169,284
+19,129
| +13% | +$2.51M | 1.95% | 23 |
|
|
2019
Q1 | $20.3M | Sell |
150,155
-15,909
| -10% | -$2.15M | 1.92% | 20 |
|
|
2018
Q4 | $16.2M | Buy |
166,064
+16,611
| +11% | +$1.62M | 1.72% | 27 |
|
|
2018
Q3 | $20.8M | Buy |
149,453
+116,065
| +348% | +$16.1M | 1.78% | 31 |
|
|
2018
Q2 | $4.15M | Buy |
33,388
+2,081
| +7% | +$258K | 0.3% | 71 |
|
|
2018
Q1 | $3.49M | Buy |
31,307
+19,771
| +171% | +$2.2M | 0.27% | 74 |
|
|
2017
Q4 | $1.38M | Buy |
+11,536
| New | +$1.38M | 0.22% | 64 |
|